Autonomix Medical, Inc. (AMIX)
2.83
-0.10
(-3.41%)
USD |
NASDAQ |
Oct 16, 13:26
Autonomix Medical SG&A Expense (TTM) : 9.318M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.318M |
| March 31, 2026 | 9.891M |
| December 31, 2025 | 10.31M |
| September 30, 2025 | 10.40M |
| June 30, 2025 | 6.892M |
| March 31, 2025 | 6.863M |
| December 31, 2024 | 6.739M |
| September 30, 2024 | 7.359M |
| Date | Value |
|---|---|
| June 30, 2024 | 5.697M |
| March 31, 2024 | 4.401M |
| December 31, 2023 | 3.164M |
| September 30, 2023 | 1.186M |
| June 30, 2023 | 1.186M |
| March 31, 2023 | 0.6833M |
| December 31, 2022 | 0.345M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Abbott Laboratories | 13.94B |
| AngioDynamics, Inc. | 116.41M |
| Alphatec Holdings, Inc. | 524.06M |
| AtriCure, Inc. | 323.68M |
| Baxter International, Inc. | 2.932B |